Office Hours: Monday - Friday 8:30am - 5:00pm

Precision Brain Health Optimization

Prevention and Reversal of Cognitive Decline Program

We are at the precipice of a new era in brain health, where to have the science and knowledge to engage in better prevention and treatment of Alzheimer's disease. As a geriatrician for the past 25 years, I have been in the trenches battling Alzheimer's and dementia. I have used all of the available traditional medications and treatments on the market with mixed success as they may help slow the progression, but inevitably the patients decline.

Precision Memory Care in Studio City, Los Angeles

We Are At the Precipice of a New Era in Brain Health, Where to Have the Science and Knowledge to Engage in Better Prevention and Treatment of Alzheimer's Disease

As a geriatrician for the past 25 years, I have been in the trenches battling Alzheimer's and dementia. I have used all of the available traditional medications and treatments on the market with mixed success as they may help slow the progression, but inevitably the patients decline.

Traditional drug treatment for Alzheimer’s disease focused on a handful of medications to slow down memory decline. The problem with the current model is that most of the therapies designed for the treatment focus on one therapy for the disease. We now realize that Alzheimer’s disease is not just one disease, it’s a spectrum of imbalances or a “network” dysfunction of body systems. Identification and restoration of the imbalances in these systems yield better outcomes in cognitive decline.

Although we still don't have a “cure” for Alzheimer's disease, we have novel science-based solutions to address the network dysfunction. We are making Alzheimer's disease a preventable and treatable disease just like heart disease and diabetes. Detection of brain dysfunction early on leads to earlier intervention and better outcomes.

The Genetics of Alzheimer's Disease: “Knowledge is Power”

Going beyond the APOE4 Gene

Scientists have long established and identified very rare genes that play a pivotal role in the development of Alzheimers disease. Now we have discovered a more common gene that predisposes someone to Alzheimer's disease called the APO - E4 gene. But the good news is if individuals with the the E4 genes have a lot of power over whether or not that risk materializes based on choices that they make. Especially if they make those choices early in life, long before symptoms set in.

Furthermore, genomics has identified over 250 genes that are linked to Alzhiemers disease and knowing your unique pattern, we can design a personalized roadmap  to avoid expressing the genes associated with cognitive impairment

Their proof-of-concept trial included 25 participants, aged 50 to 76, all with MCI (pre-Alzheimer’s) or early-stage dementia. Each patient was assessed for multiple potential contributors — inflammation, insulin resistance, nutrient and hormonal deficiencies, specific pathogens, toxicants, and biotoxins, as well as genetics — then treated with a personalized protocol that was continued for nine months. This is the same approach used by Apollo Health, which has developed software and programs to optimize the precision medicine protocol for cognitive decline.

 

Contact Our Office to Learn More and Schedule

Our Core Services

Precision Memory Care

Genomics

In-Home Care

Concierge Medicine

You deserve the best, personalized healthcare available for your overall health and well-being.

Contact Us:

Have Questions?